Patent · US Active

Anti-DLL4 antibodies and methods using same

US7803377B2 · kind B2 · utility

18Cited by
23References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 2007
Grant dateSep 28, 2010
Priority date—
Expiry dateJun 7, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-DLL4 antibodies, and compositions comprising and methods of using these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.